newsfilter
← Latest News
Business Wire·

Derma Sciences Names Pharmaceutical Development Leader John Caminis, M.D. as Chief Medical Officer

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, announces the appointment of John Caminis, M.D. to the newly created position of chief medical officer. Dr. Caminis is a seasoned pharmaceutical physician with particular expertise in clinical drug development, and will report to Edward J. Quilty, the company’s chairman and CEO.